172 related articles for article (PubMed ID: 35307806)
1. ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer.
Kroese TE; van Rossum PSN; van Hillegersberg R
Ann Surg Oncol; 2022 Aug; 29(8):4858-4860. PubMed ID: 35307806
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Multimodality Treatment in Esophageal Signet Ring Cell Adenocarcinoma.
van Hootegem SJM; Wijnhoven BPL
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):796-797. PubMed ID: 31637607
[No Abstract] [Full Text] [Related]
3. Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.
Kroese TE; van Rossum PSN; Nilsson M; Lordick F; Smyth EC; Rosati R; Nafteux P; D'Ugo D; Chaudry MA; Polkowkski W; Roviello F; Gockel I; Kolodziejczyk P; Haustermans K; Guckenberger M; Nordsmark M; Hawkins MA; Cervantes A; Fleitas T; van Cutsem E; Moehler M; Wagner AD; van Laarhoven HWM; van Hillegersberg R;
Eur J Surg Oncol; 2023 Jan; 49(1):21-28. PubMed ID: 36184420
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Oligometastatic Esophagogastric Cancer: A Spark of Light at the End of the Tunnel.
Goense L
Ann Surg Oncol; 2022 Aug; 29(8):4673-4675. PubMed ID: 35699810
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Defining Oligometastatic Recurrence in Biliary Tract Cancer.
Morino K; Yoh T; Seo S
Ann Surg Oncol; 2020 Jun; 27(6):1918. PubMed ID: 32170479
[No Abstract] [Full Text] [Related]
6. Optimal management of esophageal adenocarcinoma: should we be CROSS?
Smyth EC; Waddell TS; Cunningham D
J Clin Oncol; 2014 Sep; 32(27):3080-1. PubMed ID: 25071100
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Effectiveness of Resection of Oligometastases from Esophageal Cancer.
Ohkura Y
Ann Surg Oncol; 2020 Mar; 27(3):660-661. PubMed ID: 31907746
[No Abstract] [Full Text] [Related]
8. Reply to E. C. Smyth et al.
Hulshof MC; Oppedijk V; van der Gaast A
J Clin Oncol; 2014 Sep; 32(27):3081-2. PubMed ID: 25071131
[No Abstract] [Full Text] [Related]
9. Reply to E. C. Smyth et al.
Mamon HJ; Tepper JE
J Clin Oncol; 2014 Sep; 32(27):3082. PubMed ID: 25071102
[No Abstract] [Full Text] [Related]
10. [Comparison of recurrence patterns in esophageal carcinoma after surgery alone and surgery after neoadjuvant chemoradiotherapy: a secondary analysis of the CROSS study].
Hautmann MG; Kölbl O
Strahlenther Onkol; 2014 Jul; 190(7):696-8. PubMed ID: 25061651
[No Abstract] [Full Text] [Related]
11. Combination chemoradiation therapy: the whole is more than the sum of the parts.
Mamon HJ; Tepper JE
J Clin Oncol; 2014 Feb; 32(5):367-9. PubMed ID: 24419110
[No Abstract] [Full Text] [Related]
12. [Multidisciplinary therapy for esophagogastric junction cancer].
Sudo K; Honma Y; Kato K
Nihon Shokakibyo Gakkai Zasshi; 2015 Oct; 112(10):1791-9. PubMed ID: 26440682
[No Abstract] [Full Text] [Related]
13. Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer.
Kroese TE; Buijs GS; Burger MDL; Ruurda JP; Mook S; Brosens LAA; van Rossum PSN; van Hillegersberg R
Ann Surg Oncol; 2022 Aug; 29(8):4848-4857. PubMed ID: 35381938
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant or neoadjuvant therapy for operable esophagogastric cancer?
Moorcraft SY; Smyth EC; Cunningham D
Gastric Cancer; 2015 Jan; 18(1):1-10. PubMed ID: 24638977
[TBL] [Abstract][Full Text] [Related]
15. Evidence in follow-up and prognosis of esophagogastric junction cancer.
Sanz Álvarez L; Turienzo Santos E; Rodicio Miravalles JL; Moreno Gijón M; Amoza Pais S; Sanz Navarro S; Rizzo Ramos A
Cir Esp (Engl Ed); 2019 Oct; 97(8):465-469. PubMed ID: 31060735
[TBL] [Abstract][Full Text] [Related]
16. Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study.
Xu H; Zhang L; Miao J; Liu S; Liu H; Jia T; Zhang Q
World J Surg Oncol; 2020 Jun; 18(1):144. PubMed ID: 32593312
[TBL] [Abstract][Full Text] [Related]
17. ASO Author Reflections: Modern-Day Implementation of Robotic Esophagogastric Cancer Surgery.
Kamarajah SK; Griffiths EA; Phillips AW; Ruurda J; van Hillegersberg R; Hofstetter WL; Markar SR
Ann Surg Oncol; 2022 May; 29(5):2826-2827. PubMed ID: 34839424
[No Abstract] [Full Text] [Related]
18. [II. Treatment Strategy for Esophagogastric Junction Tumor].
Hashimoto T; Kurokawa Y; Miyazaki Y; Takahashi T; Tanaka K; Makino T; Yamazaki M; Nakajima K; Mori M; Doki Y
Gan To Kagaku Ryoho; 2018 Sep; 45(9):1248-1253. PubMed ID: 30237365
[No Abstract] [Full Text] [Related]
19. Management of Oligometastatic Disease in Esophagogastric Cancer: What Is the Evidence?
Hingorani M; Stubley H
Oncol Res Treat; 2023; 46(7-8):312-319. PubMed ID: 37331340
[TBL] [Abstract][Full Text] [Related]
20. ASO Author Reflections: Increasing Age is Associated with Increased Risk of Long-Term Mortality After Surgery and Non-operation in Esophagogastric Cancer Patients.
Kauppila JH; Mattsson F; Lagergren J
Ann Surg Oncol; 2023 May; 30(5):2726-2727. PubMed ID: 36790729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
